Nuvation Bio, Inc. (NUVB)
4.705
+0.02
(+0.53%)
USD |
NYSE |
Oct 15, 12:58
Nuvation Bio Total Long Term Debt (Quarterly) : 408.66M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 408.66M |
| March 31, 2026 | 209.36M |
| December 31, 2025 | 205.16M |
| September 30, 2025 | 200.66M |
| June 30, 2025 | 195.98M |
| March 31, 2025 | 3.839M |
| December 31, 2024 | 0.969M |
| September 30, 2024 | 0.985M |
| June 30, 2024 | 275.91M |
| March 31, 2024 | 1.509M |
| December 31, 2023 | 2.035M |
| September 30, 2023 | 2.549M |
| June 30, 2023 | 2.393M |
| Date | Value |
|---|---|
| March 31, 2023 | 2.727M |
| December 31, 2022 | 3.054M |
| September 30, 2022 | 3.372M |
| June 30, 2022 | 3.752M |
| March 31, 2022 | 2.088M |
| December 31, 2021 | 2.192M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 44.59B |
| Johnson & Johnson | 0.00 |
| Pfizer Inc. | 63.10B |
| Eli Lilly & Co. | 49.62B |
| Merck & Co., Inc. | 51.08B |